Company Filing History:
Years Active: 2020-2025
Title: Innovations by Xiaolei Tang in Gut Inflammation Treatment
Introduction
Xiaolei Tang is an accomplished inventor based in Loma Linda, CA (US). She has made significant contributions to the field of medical science, particularly in the treatment of gut inflammation. With a total of 2 patents, her work focuses on utilizing engineered dendritic cells to induce regulatory T cells.
Latest Patents
Xiaolei Tang's latest patents include a method for utilizing engineered dendritic cells to induce gut-homing regulatory T cells and treat gut inflammation. This innovative approach involves gene-modified, lymphoid-tissue-homing dendritic cells that comprise a 1-alpha-hydroxylase gene and a retinaldehyde dehydrogenase 2 gene. The 1-alpha-hydroxylase gene is expressed to produce a functional 1-alpha-hydroxylase enzyme, while the retinaldehyde dehydrogenase 2 gene is expressed to produce a functional retinaldehyde dehydrogenase 2 enzyme. This method aims to treat one or more inflammation-related conditions or diseases by administering these gene-modified cells.
Career Highlights
Xiaolei Tang is affiliated with Loma Linda University, where she continues her research and development in innovative medical treatments. Her work has garnered attention for its potential to revolutionize the way gut inflammation is treated.
Collaborations
Some of her notable coworkers include David J Baylink and K-h William Lau, who contribute to her research endeavors.
Conclusion
Xiaolei Tang's innovative work in the field of gut inflammation treatment showcases her dedication to advancing medical science. Her patents reflect a commitment to finding effective solutions for inflammation-related conditions.